Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease ; volume:20 ; number:1 ; day:9 ; month:12 ; year:2020 ; pages:1-7 ; date:12.2020
BMC cancer ; 20, Heft 1 (9.12.2020), 1-7, 12.2020
- Urheber
-
Collins, Dearbhaile Catherine
Sundar, Raghav
Constantidinou, Anastasia
Dolling, David
Yap, Timothy Anthony
Popat, Sanjay
O’Brien, Mary E.
Banerji, Udai
de Bono, Johann Sebastian
Lopez, Juanita Suzanne
Tunariu, Nina
Minchom, Anna
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07662-y
- URN
-
urn:nbn:de:101:1-2021011714375552682535
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Collins, Dearbhaile Catherine
- Sundar, Raghav
- Constantidinou, Anastasia
- Dolling, David
- Yap, Timothy Anthony
- Popat, Sanjay
- O’Brien, Mary E.
- Banerji, Udai
- de Bono, Johann Sebastian
- Lopez, Juanita Suzanne
- Tunariu, Nina
- Minchom, Anna
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Radiological review of pleural tumors
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Radiological review of pleural tumors
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Metabolic rewiring and redox alterations in malignant pleural mesothelioma
Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Radiological review of pleural tumors
Molecular biological analysis of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy